Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL

Autor: Murawski, N., Pfreundschuh, M. *, Zeynalova, S., Poeschel, V., Hänel, M., Held, G., Schmitz, N., Viardot, A., Schmidt, C., Hallek, M., Witzens-Harig, M., Trümper, L., Rixecker, T., Zwick, C.
Zdroj: In Annals of Oncology September 2014 25(9):1800-1806
Databáze: ScienceDirect